
*, ! = read with care
● = may require sign-up or subscription
— We're seeing about 75 percent efficacy by counting the reduction in numbers of malaria episodes over a year. The best vaccine prior to this was about 50 percent over a year, and lower than that over three years.
This is a material improvement, but that's not the main improvement. The big difference is how you can manufacture it at a scale that is really needed to protect most of the children who need a malaria vaccine in Africa.
— The data, which was collected from 75 countries covering 81% of the world's population, found that 91% of men and 86% of women show at least one clear bias against women in the areas of politics, economics, education, and physical integrity.
— ESG ratings look and sound like the familiar credit ratings produced by S&P, Fitch or Moody's. In reality, there are two crucial differences: analysts are not yet subject to regulatory scrutiny on conflicts of interest, and they work in part on unaudited environmental, social and governance data, rather than in audited financial statements. Only 5% of funds align with the 1.5C Paris goals on climate.
Interested in ESG? Look at the facts, not opinions (LINK)
— This year over 2800 people were in Geneva to collectively build bridges at over 70 events led by 130 organisations.
Past week UN Geneva UN Ukraine Gaza Switzerland Trump China
AI
Afghanistan Bahamas
Thailand
Putin watch
Gender
Science
Digital tools
Media
Youth
Travel